帕博利珠单抗联合化疗对亚洲PD-L1阴性的晚期非小细胞肺癌患者的疗效与安全性

    Efficacy and Safety of Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer Without Tumor PD-L1 Expression in Asian Patients

    /

    返回文章
    返回